| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/02/2009 | WO2009007412A3 Age deglycation |
| 04/02/2009 | WO2009007110A3 Combination of benzyl-4,5-dihydro-1h-imidazole derivative and an opiod recptor ligand |
| 04/02/2009 | WO2009004649A3 Enteric coated pharmaceutical compositions |
| 04/02/2009 | WO2009004214A3 Method for preparing lipid nanoparticles |
| 04/02/2009 | WO2009003001A3 Preparation of risedronate sodium hemi-pentahydrate |
| 04/02/2009 | WO2009002203A8 Polyfunctional fullerene c60 aminoacid derivatives |
| 04/02/2009 | WO2008157537A3 Compositions and methods of use for treating or preventing lipid related disorders |
| 04/02/2009 | WO2008156832A3 Renin inhibitors |
| 04/02/2009 | WO2008155357A3 Use of dopamine stabilizers |
| 04/02/2009 | WO2008153784A3 Hydroxybenzyl or hydroxypyranonemethyl esters as tyrosinase inhibitors |
| 04/02/2009 | WO2008150565A3 Ranolazine for elevated brain-type natriuretic peptide |
| 04/02/2009 | WO2008141097A9 Stereoisomers propofol therapeutic compounds |
| 04/02/2009 | WO2008139313A3 Propofol transparent anaesthetic solution with low venous irritation |
| 04/02/2009 | WO2008124651A3 Nitro-imidazole hypoxia imaging agents |
| 04/02/2009 | WO2008124000A3 Thiazole derivatives as androgen receptor modulator compounds |
| 04/02/2009 | WO2008122794A3 Breast cancer methods, medicaments and agents |
| 04/02/2009 | WO2008116920A3 17beta-hydroxysteroid-dehydrogenase type 1 inhibitors for the treatment of hormone-dependent diseases |
| 04/02/2009 | WO2008110777A3 Modulators of vegf splicing as pro- and anti-angiogenic agents |
| 04/02/2009 | WO2008110337A3 Pharmaceutical composition of quetiapine fumarate |
| 04/02/2009 | WO2008109558A4 Nucleic acid compounds for inhibiting tlr gene expression and uses thereof |
| 04/02/2009 | WO2008109495A4 Nucleic acid compounds for inhibiting cd40 gene expression and uses thereof |
| 04/02/2009 | WO2008104994A3 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application |
| 04/02/2009 | WO2008092928A4 NOVEL ß-LACTAM ANTIBIOTICS, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF |
| 04/02/2009 | WO2008088593A3 Additives and methods for enhancing active agent elution kinetics |
| 04/02/2009 | WO2008073317A3 Cytarabine for treatment of glioma |
| 04/02/2009 | WO2008070014A3 Biaryl ketone-substituted piperidines |
| 04/02/2009 | WO2008066704A3 Method of improving bioavailability for non-sedating barbiturates |
| 04/02/2009 | WO2008058355A3 Descriptive report of patent of invention of the medicament 'atorvastatin + metformin' in combined form for cardiovascular diseases |
| 04/02/2009 | WO2008058354A3 Descriptive report of the 'patent of invention of the medicament 'ramipril + metformin in combined form for cardiovascular diseases |
| 04/02/2009 | WO2008058353A3 Descriptive report of the patent of invention of the medicament 'telmisartana + metformin' in combined form for cardiovascular diseases |
| 04/02/2009 | WO2008024494A9 Pharmacokinetically improved compounds |
| 04/02/2009 | WO2008021250A3 Compositions and methods for modulating apoptosis in cells over-expressing bcl-2 family member proteins |
| 04/02/2009 | WO2008020091A8 Pharmaceutical formulation for the treatment of complaints |
| 04/02/2009 | WO2008005914A3 Novel glucokinase activators and methods of using same |
| 04/02/2009 | WO2008005451A3 Optical apparatus and methods for chemical analysis |
| 04/02/2009 | WO2007150046A3 Methods and compositions for treating ophthalmic conditions via modulation of megalin activity |
| 04/02/2009 | WO2007149312A3 Methods and compositions for inhibiting or reducing hair loss, acne, rosacea, prostate cancer, and bph |
| 04/02/2009 | WO2007140146A3 Antimicrobial composition of 3-iodo-2-propynylbutyl carbamate and 1,3-butylene glycol as solvent |
| 04/02/2009 | WO2007115164A3 Amino acid surrogates for peptidic constructs |
| 04/02/2009 | WO2007109275A3 Paclitaxel combination |
| 04/02/2009 | WO2007106450A3 Diketo acids with nucleobase scaffolds: anti-hiv replication inhibitors targeted at hiv integrase in combination therapy |
| 04/02/2009 | WO2007103711A3 Polymorphic forms of rimonabant |
| 04/02/2009 | WO2007032818A3 Compounds and compositions to control abnormal cell growth |
| 04/02/2009 | WO2007016539A3 Gtpase inhibitors and methods of use and crystal structure of rac-1 gtpase |
| 04/02/2009 | WO2007011820A3 Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| 04/02/2009 | WO2006102375A3 Methods for avoiding edema in the treatment or prevention of pparϝ-responsive diseases, including cancer |
| 04/02/2009 | WO2006101783A3 Compounds and compositions as protein kinase inhibitors |
| 04/02/2009 | WO2006023821A3 Ligands for aldoketoreductases |
| 04/02/2009 | WO2005105112A3 Hypoallergenic metal amino acid chelates and metal amino acid chelate-containing compositions |
| 04/02/2009 | WO2005102411A3 A system with a sensor for perfusion management |
| 04/02/2009 | WO2005089259A3 Method for treating aortic stenosis with non-antibacterial tetracycline formulations |
| 04/02/2009 | WO2005077006A3 Methods and compositions for detecting and treating retinal diseases |
| 04/02/2009 | WO2005067632A3 Lipid compositions and use thereof |
| 04/02/2009 | WO2005062854A3 Polyamides for nucleic acid delivery |
| 04/02/2009 | WO2005057171A3 Protein-protein interaction antagonist screening libraries based upon 1,4-disubstituted naphthalenes and related scaffolds |
| 04/02/2009 | WO2005044075A3 Compositions, splice variants and methods relating to breast specific genes and proteins |
| 04/02/2009 | WO2005039500A3 METHOD FOR THE PRODUCTION OF BIOACTIVE SUBSTANCES FROM THE NOVEL ACTINOMYCETE TAXON MAR2 (“Marinophilus”) |
| 04/02/2009 | WO2005033292A3 Methods of establishing intercellular communication in an endothelial cell layer and uses thereof |
| 04/02/2009 | WO2005020908A3 Selective inhibitors of stat-3 activation and uses thereof |
| 04/02/2009 | WO2004080394A3 Stat3 antagonists and their use as vaccines against cancer |
| 04/02/2009 | US20090088721 Enhanced retinal delivery of a nucleic acid through iontophoresis |
| 04/02/2009 | US20090088680 Optical tissue interface method and apparatus for stimulating cells |
| 04/02/2009 | US20090088569 2-amino-imidazo[4,5-d]pyridazin-4-ones, their preparation, and their use as pharmaceutical compositions |
| 04/02/2009 | US20090088568 Vinorelbine derivatives |
| 04/02/2009 | US20090088555 44 Human Secreted Proteins |
| 04/02/2009 | US20090088482 Compositions and Methods For Treating Heart Failure |
| 04/02/2009 | US20090088480 Solid forms of selective androgen receptor modulators |
| 04/02/2009 | US20090088479 Salt of aliskiren with sulfuric acid |
| 04/02/2009 | US20090088478 Novel compounds as histone deacetylase inhibitors |
| 04/02/2009 | US20090088477 Compounds and methods for leukotriene biosynthesis inhibition |
| 04/02/2009 | US20090088475 Indanone derivatives that inhibit prolyl hydroxylase |
| 04/02/2009 | US20090088474 Use of substituted cyclopropane acid derivatives for producing drugs for use in the treatment of metabolic syndrome |
| 04/02/2009 | US20090088473 Method for screening of prostaglandin compounds comprising an optimal formulation for the enhancement of hair growth and the stimulation of follicular anagen and formulations resulting therefrom |
| 04/02/2009 | US20090088472 Protective Agent for Neuronal Cell Comprising Amidino Derivative as Active Ingredient |
| 04/02/2009 | US20090088471 Chemical sterilant for adult male dog population control with concomitant reduction in human dog-bite acquired rabies |
| 04/02/2009 | US20090088470 Alkyl-, alkenyl- and alkynylcarbamate derivatives, their preparation and their application in therapeutics |
| 04/02/2009 | US20090088469 Method for the preparation of citalopram |
| 04/02/2009 | US20090088468 Novel epoprostenol formulation and method of making thereof |
| 04/02/2009 | US20090088467 Vitamin e supplementation to tetanus toxoid |
| 04/02/2009 | US20090088466 Opioid receptor ligands |
| 04/02/2009 | US20090088465 Pharmaceutical Compositions of Amorphous Atorvastatin and Process for Preparing Same |
| 04/02/2009 | US20090088464 Merged ion channel modulating compounds and Uses Thereof |
| 04/02/2009 | US20090088463 Pyrazoles Useful in the Treatment of Inflammation |
| 04/02/2009 | US20090088462 Pharmaceutical Composition for Enhancing Adiponectin Production |
| 04/02/2009 | US20090088461 Methods of Treating or Preventing Cardiac Disease Associated With a High Fat Diet |
| 04/02/2009 | US20090088460 Administration of E-3[3-[N-(4-methoxybenzenesulfonyl)-N-isopropylamino]phenyl]-3-(3-pyridyl)propenohydroxamic acid for preventing and/or treating inflammatory cutaneous pathologies/afflictions |
| 04/02/2009 | US20090088459 Novel biaryl sulfonamide derivatives |
| 04/02/2009 | US20090088458 N-(Pyridin-4-Yl)-2-Phenylbutanamides as Androgen Receptor Modulators |
| 04/02/2009 | US20090088457 Primary Amines as Renin Inhibitors |
| 04/02/2009 | US20090088456 2-Pyridinylethylcarboxamide derivatives and their use as Fugicides |
| 04/02/2009 | US20090088455 Chronic, Bolus Adminstration Of D-Threo Methylphenidate |
| 04/02/2009 | US20090088454 Anti-cancer compounds |
| 04/02/2009 | US20090088453 such as biphenyl-2-yl-carbamic acid 1- {2-[5-(4-carbamoylpiperidin-l-ylmethyl)thiophen-2-ylcarbamoyl]ethyl}piperidin-4-yl ester for treating pulmonary disorders (asthma, chronic obstructive pulmonary disease); anticholinergic agents; reduced side effects such as dry mouth and constipation |
| 04/02/2009 | US20090088452 Indole Orexin Receptor Antagonists |
| 04/02/2009 | US20090088451 Quinolines |
| 04/02/2009 | US20090088450 5-ht7 receptor antagonists |
| 04/02/2009 | US20090088449 4-acylaminopyridine derivative mediated neurogenesis |
| 04/02/2009 | US20090088448 Rapamycin Derivatives and the Uses Thereof in the Treatment of Neurological Disorders |
| 04/02/2009 | US20090088447 Solid forms of (s)-ethyl 2-amino-3-(4-(2-amino-6-((r)-1-(4-chloro-2-(3-methyl-1h-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)-pyrimidin-4-yl)phenyl)propanoate and methods of their use |
| 04/02/2009 | US20090088446 Purinone derivatives as hm74a agonists |